How are pharmaceutical technologies developed and controlled in our societies? To what extent should the availability of these technologies be determined by scientific experts, a democratic state, the interests of final users, or ethical principles? This unique collection brings together the work of social scientists, ethicists, lawyers and policy analysts on regulation, ethics and innovation in the pharmaceutical industry. Regulatory systems and their implications for public health in North America, Europe and developing countries are discussed, including case studies of norplant, interferon and anti-fertility vaccines.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
OONAGH CORRIGAN Post-Doctoral Research Fellow, Department of Sociology, Goldsmiths College, University of London, UK ARTHUR DAEMMRICH Policy Analyst and Post-Doctoral Research Fellow, Chemical Heritage Foundation CLAIRE FOSTER Secretary for Science, Medicine, Technology and Environmental Issues, Church of England's Board for Social Responsibility MORVEN HADDEN Senior Assistant in the EC and Competition Law Group of Simmons and Simmon Law Firm, London, UK ELINA HEMMINKI Research Professor, National Research and Development Centre for Welfare and Health (STAKES), Helsinki, Finland HELEN KELLY Senior Assistant, Matheson, Ormsby and Prentice Law Firm GRAHAM LEWIS Research Fellow, University of York, UK NORMA MORRIS Research Fellow, University College London, UK EEVA OLLILA Senior Research Fellow, National Research and Development Centre for Welfare and Health, Helsinki, Finland TOINE PETERS Professor in the History of Pharmacy, Groningen University, The Netherlands TIM REED Research Fellow, University of Sussex, UK JESSIKA VAN KAMMEN Project Leader, STT Netherlands Study Centre on Technology Trends
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Vendeur : Reuseabook, Gloucester, GLOS, Royaume-Uni
hardcover. Etat : Used; Good. Dispatched, from the UK, within 48 hours of ordering. This book is in good condition but will show signs of previous ownership. Please expect some creasing to the spine and/or minor damage to the cover. Ex-library book with stamps on the first page, it is also likely to have a small shelf number sticker on the spine. N° de réf. du vendeur CHL10866203
Quantité disponible : 1 disponible(s)
Vendeur : Anybook.com, Lincoln, Royaume-Uni
Etat : Good. This is an ex-library book and may have the usual library/used-book markings inside.This book has hardback covers. In good all round condition. Dust jacket in good condition. Please note the Image in this listing is a stock photo and may not match the covers of the actual item,550grams, ISBN:9780333790441. N° de réf. du vendeur 9553999
Quantité disponible : 1 disponible(s)
Vendeur : Nauka Japan LLC, Tokyo, Japon
Etat : New. [ak 5524]. N° de réf. du vendeur 14
Quantité disponible : 1 disponible(s)
Vendeur : Basi6 International, Irving, TX, Etats-Unis
Etat : Brand New. New. Delivery takes 25-30 days. Excellent Customer Service. N° de réf. du vendeur POD-58552
Quantité disponible : 10 disponible(s)
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
Etat : New. N° de réf. du vendeur 1207916-n
Quantité disponible : 15 disponible(s)
Vendeur : California Books, Miami, FL, Etats-Unis
Etat : New. N° de réf. du vendeur I-9780333790441
Quantité disponible : Plus de 20 disponibles
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Buch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -How are pharmaceutical technologies developed and controlled in our societies To what extent should the availability of these technologies be determined by scientific experts, a democratic state, the interests of final users, or ethical principles This unique collection brings together the work of social scientists, ethicists, lawyers and policy analysts on regulation, ethics and innovation in the pharmaceutical industry. Regulatory systems and their implications for public health in North America, Europe and developing countries are discussed, including case studies of norplant, interferon and anti-fertility vaccines. 278 pp. Englisch. N° de réf. du vendeur 9780333790441
Quantité disponible : 2 disponible(s)
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
Etat : New. In. N° de réf. du vendeur ria9780333790441_new
Quantité disponible : Plus de 20 disponibles
Vendeur : GreatBookPricesUK, Woodford Green, Royaume-Uni
Etat : New. N° de réf. du vendeur 1207916-n
Quantité disponible : Plus de 20 disponibles
Vendeur : Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlande
Etat : New. This collection brings together the work of social scientists, ethicists, lawyers and policy analysts on regulation, ethics and innovation in the pharmaceutical industry. Editor(s): Abraham, John; Lawton Smith, Helen. Series: Studies in Regulation. Num Pages: 288 pages, biography. BIC Classification: KNDP. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly. Dimension: 216 x 140 x 19. Weight in Grams: 477. . 2003. Hardback. . . . . N° de réf. du vendeur V9780333790441
Quantité disponible : 15 disponible(s)